<DOC>
	<DOCNO>NCT00286416</DOCNO>
	<brief_summary>Double blind protocol treatment 2/3 patient omalizumab 1/3 placebo administer 4 month . Patients select study must aspirin exacerbated respiratory disease allergic asthma rhinitis . They must also complete aspirin desensitization take aspirin daily basis treatment AERD .</brief_summary>
	<brief_title>Effect Omalizumab ( Xolair ) Treatment Patients With AERD Allergy Asthma</brief_title>
	<detailed_description>60 patient Aspirin Exacerbated respiratory Disease screen determine also allergic respiratory tract disease co-morbid complication . This involve history , allergy skin test serum IgE level . They must also desensitize aspirin take aspirin 325 650 mg morning night . 40/60 patient receive omalizumab injection every month next 4 month 20 patient , via random program , receive placebo injection . Monthly visit nurse co-ordinator involve follow assessment : daily symptom score , daily use medication ( particularly prednisone rescue albuterol inhaler ) , lung function test , nasal breathe test , measurement smell quality life score pre post study .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Omalizumab</mesh_term>
	<criteria>aspirin exacerbate respiratory disease allergic asthma pregnant female , start immunotherapy past 3 month , prior treatment Xolair , negative allergy skin test , unable participate lung function test , unable complete data form , low platelet , serum IGE great 700 iu , cancer , another uncontrolled medical condition , unacceptable concomitant medication , age 18 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>AERD</keyword>
	<keyword>aspirin</keyword>
	<keyword>allergy</keyword>
	<keyword>omalizumab</keyword>
</DOC>